Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: A low‐penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa
Open Access
- 3 June 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (6) , 1951-1958
- https://doi.org/10.1002/art.20264
Abstract
Objective To describe biochemical findings and the spectrum of mevalonate kinase (MVK) gene mutations as well as an associated TNFRSF1A low‐penetrance variant in a series of patients with clinical features of the hyperimmunoglobulinemia D with periodic fever syndrome (HIDS). Methods The MVK gene was sequenced in 8 children and 1 adult (including 2 siblings) fulfilling the clinical criteria for HIDS. In addition, sequencing of exons 2, 3, 4, and 6 of the TNFRSF1A gene was performed in patients with only one or no MVK mutation. Mevalonate kinase (MK) enzyme activity in leukocytes and renal excretion of mevalonic acid were also measured. Results Mutations in the coding region of the MVK gene were detected in 6 patients, and the most common mutation was V377I. Among these patients were 2 novel mutations, both of which were located in exon 6. These novel mutations resulted in the substitution of tryptophan (TGG) by a stop codon (TGA) at amino acid position 188 (W188X) and in the exchange of valine (GTG) for alanine (GCG) at amino acid position 203 (V203A). In 1 patient, a combination of one MVK (V377I) mutation and one TNFRSF1A (R92Q) mutation was present. The patient's clinical phenotype resembled a mixture of variant‐type HIDS and tumor necrosis factor receptor–associated periodic syndrome (TRAPS). Her IgD values varied between normal and slightly increased, and the MK activity was in the low‐normal range, while urinary mevalonate concentrations were always normal. Conclusion The genotype findings indicate that a relatively small number of genes may be involved in the clinical manifestation of HIDS, with low‐penetrance TNFRSF1A variants possibly influencing the HIDS phenotype or MVK mutations contributing to TRAPS.Keywords
This publication has 23 references indexed in Scilit:
- Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the NetherlandsEuropean Journal of Human Genetics, 2003
- The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndromeArthritis & Rheumatism, 2002
- The Structure of a Binary Complex between a Mammalian Mevalonate Kinase and ATPJournal of Biological Chemistry, 2002
- Hereditary Periodic FeverNew England Journal of Medicine, 2001
- The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic FeversAmerican Journal of Human Genetics, 2001
- Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndromeEuropean Journal of Human Genetics, 2001
- Investigation of Invariant Serine/Threonine Residues in Mevalonate KinasePublished by Elsevier ,2001
- Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndromeEuropean Journal of Human Genetics, 2001
- Hyperimmunoglobulinemia D and Periodic Fever SyndromeMedicine, 1994
- Mevalonate kinase assay using DEAE‐cellulose column chromatography for first‐trimester prenatal diagnosis and complementation analysis in mevalonic aciduriaJournal of Inherited Metabolic Disease, 1991